In this article, Robert Bergquist and Dan Colley deal with the consolidated, international efforts to generate a schistosomiasis vaccine; in particular, they summarize the deliberations of a series of meetings, held in Cairo, Egypt, 21-25 May 1997, with the aim of reviewing the current status of affairs in this respect in order to make recommendations for the future course of schistosomiasis vaccine development.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/s0169-4758(97)01207-6 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Evaluating the Immunoprotective and Diagnostic Potential of Schistosoma mansoni Epitopes from Sm050890 and Sm141290 Proteins Identified Through Reverse Vaccinology.
Acta Parasitol
January 2025
Federal University of São João del-Rei, Divinópolis, MG, Brazil.
Purpose: Schistosomiasis remains a parasitic disease affecting millions of people worldwide, requiring interventions like vaccination. In previous work, our group used reverse vaccinology to identify two epitopes from the Schistosoma mansoni proteins, Sm050890 (44-58) and Sm141290 (225-239). This study evaluated the immune response profile and protection induced by peptides, as a mixture of immunogens, in murine vaccination trials.
View Article and Find Full Text PDFSchistosoma sex-biased microRNAs regulate ovarian development and egg production by targeting Wnt signaling pathway.
Commun Biol
December 2024
Shanghai Tenth People's Hospital, Institute for Infectious Diseases and Vaccine Development, School of Medicine, Tongji University, Shanghai, China.
Adult Schistosoma produces a large number of eggs that play essential roles in host pathology and disease dissemination. Consequently, understanding the mechanisms of sexual maturation and egg production may open a new avenue for controlling schistosomiasis. Here, we describe that Bantam miRNA and miR-1989 regulate Wnt signaling pathway by targeting Frizzled-5/7/9, which is involved in ovarian development and oviposition.
View Article and Find Full Text PDFMathematical model of voluntary vaccination against schistosomiasis.
PeerJ
December 2024
Department of Mathematics and Applied Mathematics, Virginia Commonwealth University, Richmond, VA, United States of America.
Article Synopsis
- Human schistosomiasis, caused by Schistosoma worms, is a neglected tropical disease prevalent in sub-Saharan Africa, currently lacking a vaccine despite ongoing development.
- The study improves a compartmental model of schistosomiasis by adding human behavior and voluntary vaccination factors, highlighting that effective herd immunity requires specific vaccination rates.
- Results show that unless vaccination costs are low, voluntary vaccination alone may not sufficiently lower disease prevalence below 1%, emphasizing the need for affordable vaccine access to achieve public health goals.
COVID-19 vaccination survey and anti-SARS-CoV-2 IgG responses in a human cohort from -endemic villages in Mayuge District, Uganda: a cross-sectional study.
Front Public Health
December 2024
Molecular Parasitology Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
Article Synopsis
- The COVID-19 pandemic has had severe health and economic impacts globally, with vaccination being crucial for control, especially in regions with high rates of helminth infections, which could affect vaccine responses.
- A study in Uganda surveyed 450 individuals to assess helminth prevalence and COVID-19 vaccine responses; results showed high infection rates of schistosomiasis (36.4%) and hookworms (36.9%), with 93.14% vaccination coverage among a smaller group interviewed.
- Despite widespread vaccination, a significant portion of those vaccinated had low anti-S1 IgG antibody levels, indicating that helminth infections might reduce vaccine efficacy among individuals with moderate to heavy infections.
Vaccine value profile for schistosomiasis.
Vaccine
July 2024
World Health Organization, Geneva, Switzerland.
Article Synopsis
- * In 2019, approximately 236.6 million people required treatment for schistosomiasis, highlighting its significant impact on fishing and agricultural communities.
- * The Vaccine Value Profile (VVP) is a comprehensive assessment created by a group of experts to evaluate the public health and economic potential of new vaccines targeting schistosomiasis, emphasizing the need to address existing research gaps.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!